| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Becton Dickinson and Company (NYSE: BDXB)
BDXB Technical Analysis
4
| As on 31st May 2023 BDXB STOCK Price closed @ 48.16 and we RECOMMEND Sell for LONG-TERM with Stoploss of 51.08 & Strong Sell for SHORT-TERM with Stoploss of 53.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BDXBSTOCK Price
| Open | 47.20 | Change | Price | % |
| High | 48.93 | 1 Day | 0.66 | 1.39 |
| Low | 47.20 | 1 Week | -2.16 | -4.29 |
| Close | 48.16 | 1 Month | -2.09 | -4.16 |
| Volume | 2764300 | 1 Year | -2.36 | -4.67 |
| 52 Week High 55.45 | 52 Week Low 45.89 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| BDXB Daily Charts |
BDXB Intraday Charts |
Whats New @ Bazaartrend |
BDXB Free Analysis |
|
|
BDXB Important Levels Intraday
| RESISTANCE | 51.49 |
| RESISTANCE | 50.42 |
| RESISTANCE | 49.76 |
| RESISTANCE | 49.10 |
| SUPPORT | 47.22 |
| SUPPORT | 46.56 |
| SUPPORT | 45.90 |
| SUPPORT | 44.83 |
BDXB Forecast May 2024
| 4th UP Forecast | 56.33 |
| 3rd UP Forecast | 53.71 |
| 2nd UP Forecast | 52.09 |
| 1st UP Forecast | 50.47 |
| 1st DOWN Forecast | 45.85 |
| 2nd DOWN Forecast | 44.23 |
| 3rd DOWN Forecast | 42.61 |
| 4th DOWN Forecast | 39.99 |
BDXB Weekly Forecast
| 4th UP Forecast | 52.57 |
| 3rd UP Forecast | 51.16 |
| 2nd UP Forecast | 50.28 |
| 1st UP Forecast | 49.41 |
| 1st DOWN Forecast | 46.91 |
| 2nd DOWN Forecast | 46.04 |
| 3rd DOWN Forecast | 45.16 |
| 4th DOWN Forecast | 43.75 |
BDXB Forecast2024
| 4th UP Forecast | 67.6 |
| 3rd UP Forecast | 61.37 |
| 2nd UP Forecast | 57.51 |
| 1st UP Forecast | 53.66 |
| 1st DOWN Forecast | 42.66 |
| 2nd DOWN Forecast | 38.81 |
| 3rd DOWN Forecast | 34.95 |
| 4th DOWN Forecast | 28.72 |
Becton Dickinson and Company ( NYSE USA Symbol : BDXB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BDXB Business Profile
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey. Address: 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service